Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Walgreens Boots Alliance (NQ: WBA )

9.000 +0.270 (+3.09%)
Streaming Delayed Price Updated: 1:40 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Walgreens Boots Alliance

< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
69 70 Next >
Failed Breakouts (QQQ $400, IWM $200), WBA: Good Enough
Walgreens reported a “good enough” quarter and I suspect the stock has now put in a sustainable bottom at $20. 
Via Talk Markets
Earnings Scheduled For January 4, 2024
Companies Reporting Before The Bell • Lamb Weston Hldgs (NYSE:LW) is likely to report quarterly earnings at $1.41 per share on revenue of $1.70 billion. 
Via Benzinga
Nasdaq, S&P 500 Futures Waver As Hawkish Fed Minutes Leave Investors Data-Watching: Analyst Thinks Weak Santa Claus Rally Signals 'Potential Warning'
U.S. stock futures are slightly higher on Thursday following the lackluster performance seen in recent sessions. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Walgreens Boots Alliance Reports Fiscal 2024 First Quarter Results
From Walgreens Boots Alliance
Via Business Wire
Earnings Outlook For Walgreens Boots Alliance
Via Benzinga
Value In WBA
If Walgreens can report an inline quarter on Thursday morning, I think the stock could finally be on its way. 
Via Talk Markets
Peering Into Walgreens Boots Alliance's Recent Short Interest
Via Benzinga
Walgreens Boots Alliance Declares Quarterly Dividend
From Walgreens Boots Alliance
Via Business Wire
Fear & Greed Index Moves To 'Greed' Zone; Nasdaq Tumbles For 4th Consecutive Day
The CNN Money Fear and Greed index showed a further decline in overall market sentiment, with the index moving to the "Greed" zone on Wednesday. U.S. stocks closed lower on Wednesday following the... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Walgreens, Conagra Brands And 3 Stocks To Watch Heading Into Thursday
With U.S. stock futures trading higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
New Year, New Gains: The 3 Best Value Stocks to Buy in 2024
With an economic recovery on the horizon, it's time to scoop up the highest quality value stocks while they remain bargains. 
Via InvestorPlace
Walgreens Likely To Report Lower Q1 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is projected to release financial results for its fiscal 2024 first quarter, before the opening bell on Jan. 4, 2023. 
Via Benzinga
KKR-Backed BrightSpring Health Services Sets Sail For IPO, Aiming To Curtail Debt
KKR & Co Inc (NYSE: KKR) backed BrightSpring Health Services, Inc. filed for an initial public offering ( 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
4 takeaways from the first day of trading in 2024
The first trading day of 2024 was not good and left the market with an ominous signal of impending correction; safe-haven high-yield values come into favor. 
Via MarketBeat
Topics Stocks
Exposures US Equities
Should You Buy the S&P 500's Highest-Paying Dividend Stocks to Start 2024?
Question marks surrounding these companies may be a reason for caution for investors. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Dogs Of The Dow: Top 10 Highest Yielding Dow Jones Stocks, How To Get Dividends Of 3% to 7.4% In 2024
Twenty eight of the 30 Dow Jones Industrial Average components pay out dividends. A look at the top ten highest dividend yields. 
Via Benzinga
Topics Stocks
Exposures US Equities
5 Biggest Winners, 5 Biggest Losers From Dow Jones Industrial Average In 2023
A look back at the best performing and worst performing Dow Jones Industrial Average stocks in 2023. 
Via Benzinga
Topics Stocks
Exposures US Equities
Consulting Firm McKinsey Concludes Opioid Litigation Settlement With $78M Agreement
Consulting giant McKinsey & Co, on Friday, agreed to a settlement of $78 million to resolve allegations tied to the opioid epidemic, as disclosed in federal court papers filed in San Francisco.  
Via Benzinga
Will Walgreens Boots Alliance's Dividend Growth Streak End in 2024?
It's time for Walgreens to make a decision about its dividend. 
Via The Motley Fool
3 Beaten-Down Dow Jones Stocks That Dividend Investors Should Scoop Up in 2024
These "Dogs of the Dow" offer attractive dividend yields and upside potential. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
How Will Earnings Estimates Evolve In 2024?
The higher-for-longer view of interest rates has been modified by the Fed outlook that suggests the central bank is getting ready to start easing in the New Year. This has direct earnings implications,... 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Why the Dogs of the Dow Were a Big Disappointment in 2023
After finally breaking through in 2022 with a solid showing, this popular strategy underperformed the broader Dow Jones Industrials for the fifth year out of six. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
There Are Only 5 Dow Stocks I Wouldn't Buy in 2024
There's a lot to like about Apple, Microsoft, and most of the Dow Jones Industrial Average components in 2024. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Financial Freedom: 7 Exceptional High-Yield Stocks for Lasting Passive Gains
Are you looking for your financial freedom? Here are seven exceptional high-yield stocks for lasting passive gains. 
Via InvestorPlace
If you buy the dogs, should you sell these Dow leaders?
The Dogs of the Dow is a great strategy for value and income, but letting the winners run is equally essential to maximize returns. 
Via MarketBeat
Topics Stocks
Exposures US Equities
Pharmaceutical Giants Brace for Showdown as Medicare Drug Price Negotiations Are Poised For 2024
2024 will mark a pivotal moment for the healthcare industry, particularly in drug pricing negotiations. 
Via Benzinga
Are high-yield Dow Dogs a good buy for 2024?
These Dow Dogs are also the highest-yielding names on the Dow list. All are trading near recent bottoms and pay above-average yields with an average above 6%. 
Via MarketBeat
Topics Stocks
Exposures US Equities
Is It Time to Buy the Dow Jones' 3 Worst Performing Stocks This Year?
These stocks have significantly underperformed the market. But are they really "cheap"? 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Net Lease Walgreens Sold by The Boulder Group
Via AB Newswire
29 Undervalued Dividend Aristocrats: December 2023
The S&P 500 Dividend Aristocrats Index contains 67 dividend growth stocks called the Dividend Aristocrats. 
Via Talk Markets
Topics Stocks
Exposures US Equities
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
69 70 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.